Ignite Creation Date:
2024-07-17 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470750
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-06-18
Brief Title:
Feasibility of Patient-Centered Home Care PCHC to Reduce Disparities in High-Risk Black Men BM With Advanced Prostate Cancer CaP
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Feasibility of Patient-Centered Home Care PCHC to Reduce Disparities in High-Risk Black Men BM With Advanced Prostate Cancer CaP
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the possibility of patient-centered home care as a new model of cancer care to reduce disparities and improve health related quality of life and patient-reported outcomes in Black patients with advanced prostate cancer
Detailed Description:
PRIMARY OBJECTIVES
I To evaluate a highly innovative project evaluating the feasibility of patient-centered home care PCHC as a new model of cancer care to reduce disparities and improve health related QoL HRQoL and patient reported-outcomes PROs in Black patients with advanced prostate cancer CaP Phase I II Establish patient-centeredness by exploring patients choice relative to the place of CaP treatment for certain aspects of therapy as well as end-of-life care
III Establish the acceptance and impact of PCHC on PROs and HRQoL in BM with advanced CaP
OUTLINE This is an observational study Participants are assigned to 1 of 2 groups
GROUP 1 Participants take part in a focus group or complete questionnaires and may take part in an interview on study
GROUP 2 Participants complete questionnaires throughout the study
I To evaluate a highly innovative project evaluating the feasibility of patient-centered home care PCHC as a new model of cancer care to reduce disparities and improve health related QoL HRQoL and patient reported-outcomes PROs in Black patients with advanced prostate cancer CaP Phase I II Establish patient-centeredness by exploring patients choice relative to the place of CaP treatment for certain aspects of therapy as well as end-of-life care
III Establish the acceptance and impact of PCHC on PROs and HRQoL in BM with advanced CaP
OUTLINE This is an observational study Participants are assigned to 1 of 2 groups
GROUP 1 Participants take part in a focus group or complete questionnaires and may take part in an interview on study
GROUP 2 Participants complete questionnaires throughout the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2024-04792 | REGISTRY | None | None |
| 22-004375 | OTHER | None | None |
| CaP PCHC | OTHER | None | None |
| W81XWH2210969 | OTHER_GRANT | None | None |
| W81XWH2210968 | OTHER_GRANT | None | None |